Recent Updates
Recently added Catalysts
UFPT Positive Sentiment

UFP Technologies Announces Strong Q3 Results

Tuesday, November 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: UFP Technologies reported a strong financial performance for Q3 2026, with net income rising to $20.6 million, a 25.8% increase from $16.4 million in Q3 2025. The company's net sales for the quarter were $172.4 million, reflecting robust growth in its contract development and manufacturing operations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Net income increased by 25.8% year-over-year.
  • Reported net income of $20.6 million.
  • Net sales reached $172.4 million.

Full Press Release Details

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.6 million for its third quarter ended September 30, 2026, 25.8% higher than net income of $16.4 million for the third quarter of 2025. Net sales for the quarter ended September 30, 2026 were $172.4 millio

Frequently Asked Questions

What was UFP Technologies' net income for Q3 2026?

UFP Technologies reported a net income of $20.6 million.

How much did net income increase compared to Q3 2025?

Net income increased by 25.8% from $16.4 million in Q3 2025.

What were the net sales for UFP Technologies in Q3 2026?

Net sales for the quarter were $172.4 million.

When did UFP Technologies report its Q3 results?

The Q3 results were reported for the quarter ended September 30, 2026.

ShareAdd on Google
Tags: UFPT UFP Technologies Q3 2026 net income financial results
Last updated: Nov 3, 2026

Biotech snapshot

Cash runway
$9M liquidity · $0M/mo burn
Low dilution risk